Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/KISSEI-PHARMACEUTICAL-CO--6492249/news/Kissei-Pharmaceutical-Marketing-Approval-for-Ulcerative-Colitis-Treatment-RECTABUL-2-mg-Rectal-25182292/?utm_source=whatsapp&utm_medium=social&utm_campaign=share